Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
Authors
Keywords
-
Journal
Infection and Drug Resistance
Volume Volume 15, Issue -, Pages 2091-2100
Publisher
Informa UK Limited
Online
2022-04-21
DOI
10.2147/idr.s353127
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
- (2022) Qi Xiang et al. MICROBIOLOGICAL RESEARCH
- Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile
- (2022) M Elvira Balcells et al. CLINICAL INFECTIOUS DISEASES
- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
- (2021) Sharon Amit et al. LANCET
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2021) Zhiwei Wu et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
- (2021) Shilong Yang et al. LANCET INFECTIOUS DISEASES
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
- (2021) Nicholas G. Davies et al. NATURE
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
- (2021) Itzchak Levy et al. CLINICAL MICROBIOLOGY AND INFECTION
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- (2021) Aziz Sheikh et al. LANCET
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
- (2021) Pinja Jalkanen et al. Nature Communications
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
- (2021) John Frater et al. Lancet HIV
- T follicular helper cells in the humoral immune response to SARS‐CoV‐2 infection and vaccination
- (2021) Marios Koutsakos et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India)
- (2021) Nitin Khandelwal et al. Frontiers in Cellular and Infection Microbiology
- Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
- (2021) Felipe Melo-González et al. Frontiers in Immunology
- Prioritise people with HIV for COVID-19 vaccination
- (2021) The Lancet HIV Lancet HIV
- Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data
- (2021) Xueying Yang et al. Lancet HIV
- COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity
- (2021) Ying Liu et al. Vaccines
- Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
- (2020) Jianhui Nie et al. Nature Protocols
- Determinants of suboptimal CD4 + T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection
- (2020) Ryan Handoko et al. Journal of the International AIDS Society
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
- (2019) Shane Crotty IMMUNITY
- No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi
- (2018) A.B. Ibarz-Pavon et al. VACCINE
- Current status on the development of pseudoviruses for enveloped viruses
- (2017) Qianqian Li et al. REVIEWS IN MEDICAL VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started